Inhaled Pentamidine For Pneumocystis jiroveci Prophylaxis in a Heart Transplant Recipient With Allergy for Trimethoprim Sulfamethoxazole

Abstract

Pneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprim-sulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to trimethoprim sulfamethoxazole.